Assessment of breast lesions using Doppler with contrast agents

Objective: To evaluate the use of contrast agents on ultrasound examination of breast lesions and to analyse the capacity of this technique to achieve a differential diagnosis of benign and malignant lesions, using as a pattern a histological study of the lesions.

Materials and methods: Seventy-two women with suspected malignant breast lesions participated in this randomised prospective study, undergoing a colour Doppler ultrasound (US). The results of the study were measured before and after the use of US contrast agents and were compared with the ones obtained from the histological study of the pieces.

Results: Malignant breast tumours showed, when using US Doppler with contrast agent, a hypervascularity pattern in 78.1% of the cases. The predominant pattern in benign tumours was avascular (11 cases, 64.7%). The intensity of the signal in the first minute was intense in 43.7% or moderate in 40.6% of the cases with malignant tumours versus the benign tumours where no signal was registered in 64.7% of the cases. A marked increase in the sensitivity and the predictive negative value of the ultrasound signal was noted with the use of potentiating substances.

Conclusions: The use of contrast agents in colour Doppler US studies improve the differential diagnosis of benign and malignant breast lesions.

Breast; Doppler; Contrast agent

[1] Rajendra P., Kendar R.P., McCready V.R., Bamber J.C., Carter E.R.: "Breast carcinoma. Measurement of tumor response to primary medical therapy with color Doppler flow imaging". Radiology, 1994, 190, 825.

[2] Rajendra P., Kendar R.P., Cosgrove D.O., McCready V.R., Bamber J.C., Carter E.R.: "Microbubble contrast agent for color Doppler US: Effect on breast masses". Radiology, 1996, 198, 679.

[3] Menna S., Virg山o VI., Burke P.: "Ultrasonography contrast media Levovist and power Doppler in the study of the breast. Methodology, vascular morphology and automatIC enhacement quantlfication with wash-in and wash-out curves". Radio!. Med., 1999, 97, 472.

[4] Cosgrove D.O.: "Ultrasound contrast enhancement of tumours". Clin. Radiol., 1996, 51, 44.

[5] Sabine H., Thoma H., Joachim K., Dock W., Zuna I., Delorme S.: "Effects of a microbubble contrast agent on breast tumors: Computer-assisted quantitative assessment with color Doppler US -early experience". Radiology, 1998, 208, 485.

[6] Lanfranchi M.E.: "Angiogenesis tumoral Doppler color. Power 3D power. Potenciadores de sefial". Ecografia mamaria, 2000, 13, 205.

[7] Huber S., Vessely M., Zuna I.: 'Fibroadenomas: computer -assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology". Ultras. Med. Biol., 2001, 27, 3.

[8] Stuhrmann M., Schwarz T., Schietzel M.: "Breast cancer recurrence versus scar. Ultrasonographic differentiation using Levovist as the contrast medium". Ultraschall Med., 2001, 22, 2.

[9] Winehouse J., Douek M., Holz H., Madjar H.: "Contrast-enhanced colour Doppler ultrasonography in suspected breast cancer recurrence". Br. J. Surg., 1999, 86, 1198.

[10] Hagay C., Chere! P.J., de Maulmont C.E.: "Contrast-enhanced CT: value for diagnosis local breast cancer recurrence after conservative treatment". Radiolog},·1996, 200, 631.

[11] Stuhrman M., Aronius R., Schietzel M.:'Tumor vascularity of breast lesions: potentials and limits of contrast-enhanced Doppler sonography". Am. J. Roentgenol., 2000, 175, 1585.

[12] Moon W.K., Im J.G., Noh D.Y., Han M.C.: "Nonpalpable breast lesions: evaluation with power Doppler US and microbuble contrast agent - initial experience". Radiology, 2000, 217, 240.